A study result has shown that inhibiting the activity of the Anoctamin-1 (ANO1) protein may be effective in treating psoriasis, an intractable skin disorder.

The results are expected to aid further research in developing ANO1 inhibitors for the treatment of intractable diseases such as psoriasis and cancer.

On the 4th, the joint research team of Gyeonggi-do Regional Research Center and Professor Young Duk Yang’s team at the CHA University School of Medicine announced the results of the study that contained these findings.

Psoriasis is an intractable skin condition that causes a build-up of extra dead cells and inflammation that occurs due to abnormal function of the immune sy